March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Complement Play A Minor Role In Mouse Laser-induced Choroidal Neovascularization
Author Affiliations & Notes
  • Stephen H. Poor
    Ophthalmology, Novartis, Cambridge, Massachusetts
  • Elizabeth Fassbender
    Ophthalmology, Novartis, Cambridge, Massachusetts
  • Siyuan Shen
    Ophthalmology, Novartis, Cambridge, Massachusetts
  • Yubin Qiu
    Ophthalmology, Novartis, Cambridge, Massachusetts
  • Amber Woolfenden
    Ophthalmology, Novartis, Cambridge, Massachusetts
  • John Demirs
    Ophthalmology, Novartis, Cambridge, Massachusetts
  • Karen Anderson
    Ophthalmology, Novartis, Cambridge, Massachusetts
  • Bruce D. Jaffee
    Ophthalmology, Novartis, Cambridge, Massachusetts
  • Footnotes
    Commercial Relationships  Stephen H. Poor, Novartis Institute of Biomedical Research, Department of Ophthalmology (F); Elizabeth Fassbender, Novartis Institute of Biomedical Research, Department of Ophthalmology (F); Siyuan Shen, Novartis Institute of Biomedical Research, Department of Ophthalmology (F); Yubin Qiu, Novartis Institute of Biomedical Research, Department of Ophthalmology (F); Amber Woolfenden, Novartis Institute of Biomedical Research, Department of Ophthalmology (F); John Demirs, Novartis Institute of Biomedical Research, Department of Ophthalmology (F); Karen Anderson, Novartis Institute of Biomedical Research, Department of Ophthalmology (F); Bruce D. Jaffee, Novartis Institute of Biomedical Research, Department of Ophthalmology (F)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 1642. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Stephen H. Poor, Elizabeth Fassbender, Siyuan Shen, Yubin Qiu, Amber Woolfenden, John Demirs, Karen Anderson, Bruce D. Jaffee; Complement Play A Minor Role In Mouse Laser-induced Choroidal Neovascularization. Invest. Ophthalmol. Vis. Sci. 2012;53(14):1642.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To investigate the role of complement in laser-induced choroidal neovascularization (CNV) in mice

Methods: : Retina photocoagulation lesions in C57BL/6 mice were generated with an Iridex Oculight® GLx 532 nm laser (3 lesions/eye, 6 lesions/mouse, 10 mice/cohort, yielding 60 data points per cohort). On day 7, mice were injected iv with vascular label and euthanized. CNV lesions were photographed by fluorescent microscopy and lesion area was measured with Axiovision software. Data was masked during image acquisition, application of exclusion criteria, and analysis. Wild-type and complement-deficient (or drug-treated) mice in each experiment were age and sex matched and derived from a single vendor. Inter-group differences were analyzed by one-way analysis of variance (ANOVA) with a Neuman-Keuls post hoc analysis or an unpaired two tailed t test. Mice investigated included knockouts (KO’s) of C3, factor D, factor B, C5, C5a receptor or C6 on a C57/Bl6 Jackson background and CFH KO’s and C3 KO’s on a Taconic background. In some experiments, wild type mice were treated with complement modifying drugs including systemic administration of cobra venom factor, a serine protease inhibitor (Nafamostat), a covalent inhibitor of factor D (Biocryst), and a LMW C5aR antagonist (PMX53) as well as intravitreal administration of PMX53.

Results: : The areas of CNV were significantly larger in C3, C5 and C6 KO mice compared to C57/Bl6 mice on a Jackson background. The areas in Factor D & B KO’s were not different from C57/Bl6 controls. C3 KO mice on a Taconic background developed CNV lesions with areas similar in size as C57/Bl6 controls. Factor H KO and heterozygote mice on a Taconic background developed significantly smaller areas of CNV compared to C57/Bl6 controls. All drugs tested did not significantly inhibit the area of CNV. We also observed that Taconic mice develop an area of CNV ~ 3 fold larger than mice from the Jackson lab.

Conclusions: : We note that the mice derived from different vendors have markedly different responses to laser photocoagulation. The differences in CNV area observed between KO mice and controls may be explained by variation in the origin of mice. We reccommend that sibling controls are used for future experiments.Our experimental results to date indicate that complement deficiency plays at most a minor role in mouse laser-induced CNV. Our observations are in contrast to published findings from other groups that found complement deficiency reduced the size or completely inhibited the area of laser-induced CNV. We note that laser-induced CNV in mice has a different pathogenesis than wet AMD

Keywords: choroid: neovascularization • pathology: experimental • immunomodulation/immunoregulation 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×